QuickView for FAD-dependent oxidoreductase 2, FAD binding domain (biogroup)

1. Yeast cells with Scc2 knockout in the absence and presence of DNA damage
2. L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
3. L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (2 of 2)
4. L1000 CMAP Prostate cancer VCaP cells with gene overexpression perturbations
5. L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)

There were no matches for FAD-dependent oxidoreductase 2, FAD binding domain

There were no clinical trials for FAD-dependent oxidoreductase 2, FAD binding domain